Anthropic launched a physical biology facility in the San Francisco Bay Area to transition its research from computer simulations to real world experiments. The company integrates its Claude AI to direct laboratory robots in performing tasks with limited human intervention. This wet lab environment enables the business to move beyond in silico evaluations into physical biological work.

The facility operates on a preclinical basis and does not conduct clinical trials. A spokesperson said the lab is not designed specifically for drug discovery, although the company aims to research treatments for rare diseases. This expansion requires the company to apply its AI safety rules to physical lab work.